BUY BSE Ltd. — Motilal Oswal
byMotilal OswalHorizon: NA (inferred 1 year)24 Oct 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
BSE Index Services launches 14 new sectoral indices
NewsCnbc-Tv18·13 Nov · yesterday
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·13 Nov · yesterday
BSE Share Price Gains Over 2% After ICICI Securities Upgrades Rating To 'Add', Raises Target
NewsNdtv-Profit·11 Nov · 3d ago
5 advisors have active short-term BUY calls on this stock, with 3 issued in the last 14 days
Advisor consensus · adjacent horizon·9 Nov · 5d ago
10 other SEBI-registered advisors have active long-term BUY calls on this stock, with 3 issued in the last 14 days
Advisor consensus · same horizon·9 Nov · 5d ago
CAS weighs on NSE, BSE Q2 earnings; MCX rides gold, silver volatility
NewsLivemint·9 Nov · 5d ago
BSE Q2 Review: Jefferies Maintains 'Underperform' Call, Raises Target Price
NewsNdtv-Profit·5 Nov · 1w ago
BSE Share Price: What is the fair value that divided analysts see for the stock after Q2 results
NewsCnbc-Tv18·5 Nov · 1w ago
Q2 Results Today Highlights: BSE, Apollo Hospitals, Sundaram Finance post higher profit in Q2; Biocon, Zydus Life profit declines
NewsHbl·4 Nov · 1w ago
BSE begins hunt for MD & CEO successor ahead of 2027 exit
NewsEt-Markets·24 Oct · 3w ago
2 other SEBI-registered advisors have active long-term SELL calls on this stock, with 1 issued in the last 14 days
Advisor consensus · same horizon·5 Nov · 1w ago
BSE Q2 Results: Profit Dips Sequentially. A 24% Fall In Derivatives Premium Turnover To Be Blamed?
NewsNdtv-Profit·4 Nov · 1w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on BSE
- BUY — Sumeet Bagadia, Choice Broking12 Nov 2026 · ~2 weeks · target ₹4,025 · Active
- BUY — Shivangi Sarda, Motilal Oswal11 Nov 2026 · ~2 weeks · target ₹4,050 · Active
- BUY — Rachna Vaidya11 Nov 2026 · ~2 weeks · target ₹3,950 · Target hit
- BUY — Chandan Taparia, Motilal Oswal9 Nov 2026 · ~1 year · target ₹4,400 · Active
- BUY — Chandan Taparia, Motilal Oswal9 Nov 2026 · ~3 months · target ₹4,200 · Active
More from Motilal Oswal
- BUY Gland Pharma12 Nov 2026 · ~1 year · target ₹3,690 · Active
- BUY GNG Electronics12 Nov 2026 · ~1 year · target ₹840 · Active
- BUY Triveni Turbine12 Nov 2026 · ~1 year · target ₹610 · Active
- BUY TURTLEMINT FINTECH SOLUTIONS12 Nov 2026 · ~1 year · target ₹75 · Active
- BUY Coromandel International12 Nov 2026 · ~1 year · target ₹2,400 · Active

